Ameritas Investment Partners’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Ameritas Investment Partners’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-994	Closed	-$28K	–	3077
2019 Q3	$28K	Hold	994	–	–	﹤0.01%	2222
2019 Q2	$14K	Hold	994	–	–	﹤0.01%	2672
2019 Q1	$9K	Hold	994	–	–	﹤0.01%	2749
2018 Q4	$8K	Hold	994	–	–	﹤0.01%	2764
2018 Q3	$21K	Hold	994	–	–	﹤0.01%	2493
2018 Q2	$30K	Buy	994 +559	+129%	+$15.2K	﹤0.01%	2288
2018 Q1	$12K	Hold	435	–	–	﹤0.01%	2675
2017 Q4	$13K	Buy	+435	New	+$11.9K	﹤0.01%	2681

Ameritas Investment Partners's DOVA Position: Q4 2019 in Review

Ameritas Investment Partners sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 994 shares — an estimated $28K sold.

Ameritas Investment Partners first reported a position in DOVA in Q4 2017 and held it in 8 quarters. The position peaked at $30K in Q2 2018. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Ameritas Investment Partners reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Ameritas Investment Partners sold 994 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $28K.
Ameritas Investment Partners first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 8 quarters.
Ameritas Investment Partners's Dova Pharmaceuticals, Inc. Common Stock position peaked at $30K in Q2 2018.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Ameritas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.